$IMNN

Imunon, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Lawrenceville, NJ

IMNN chart

What traders are saying about $IMNN

Latest posts

Imunon, Inc. news

Imunon, Inc. key financials

USD2025202420232022
Revenue–––$500,000
Net income$14.5M-$18.6M-$19.5M-$35.9M
Diluted EPS$-6.83$-16.94$-2.16$-5.03
Total assets (year end)$12.3M$9.7M$21.9M$44.0M
Cash and equivalents (year end)$8.8M$5.9M$5.8M$11.5M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • S-1S-1
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K

About Imunon, Inc.

Ticker
IMNN (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Lawrenceville, NJ
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
749647
Former names
CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC

Frequently asked questions

What exchange is Imunon, Inc. listed on?

Imunon, Inc. trades on the Nasdaq under the ticker symbol IMNN.

What industry is Imunon, Inc. in?

Imunon, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Imunon, Inc. headquartered?

Imunon, Inc.'s business address on file with the SEC is in Lawrenceville, NJ.

When does Imunon, Inc.'s fiscal year end?

Imunon, Inc.'s fiscal year ends on December 31.

How much revenue did Imunon, Inc. report?

Imunon, Inc. reported $500,000 in revenue for calendar year 2022, according to its SEC filings.